INDIANAPOLIS, IN, Equinom, a ‹‹company on a mission to cultivate better food from the ground up, has announced a $35 million tranche of funding to bring more of its optimized plant protein ingredients to market.

The capital raise was led by Synthesis Capital (Synthesis), a leading global food technology and alternative protein investor, with additional investment from Praesidium, Bunge Ventures, the for-profit global investment arm of Bunge, BayWa, CPT Capital and returning investors Fortissimo and Phoenix. This brings the total funding for Equinom to over $71 million to date.